PROBIAL Vision Dry
Ophthalmology
- Strengthens the defenses of the ocular surface
- Supports resolution of dry eye disease
- Reduces conjunctival aerobic and anaerobic microbes
Bifidobacterium lactis BS01 (LMG P-21384)
Lactobacillus acidophilus LA02 (DSM 21717)
Lacticaseibacillus paracasei LPC00 (LMG P-21380)
Lacticaseibacillus rhamnosus LR06 (DSM 21981)
Lactiplantibacillus plantarum LP02 (LMG P-210120)
Ligilactobacillus salivarius LS03 (DSM 22776)
FOS (fructooligosaccharides)
Vitamin A
EFSA Claim: contributes to normal vision
Dry Eye Disease (DED) is a prevalent condition, affecting over 5% of the global population. It is characterized by persistent irritation, a sensation of a foreign body in the eye, blurred vision, and can significantly interfere with work and daily activities [1].
Common treatments for DED involve artificial tears with hyaluronic acid, topical steroids, anti-inflammatories, cyclosporin A, and tetracyclines [2]. Recent studies have also shed light on the influence of gut microbiota on DED, including its association with Sjögren’s syndrome [3].
PROBIAL® Vision Dry is a specially formulated complex probiotic blend designed to target bacterial overgrowth and gut dysbiosis, as well as inflammation and oxidative stress. It has been clinically demonstrated to improve both the symptoms and condition of DED [4].
In a clinical trial, PROBIAL® Vision Dry [4], when added to artificial tears treatment for 30 days in subjects with DED displaying signs of discomfort and/or dry eye, showed significant benefits compared to the placebo group (which received artificial tears only):
It improved the condition of dry eye disease, significantly strengthening the defense of the ocular surface systems.
It reduced the total number of aerobes and anaerobes bacteria isolated from conjunctival swabs.
These findings suggest that PROBIAL® Vision Dry can be an effective supplement to conventional treatments for DED, offering relief from symptoms and contributing to the overall health of the ocular surface.
1. Rouen PA, White ML. Dry Eye Disease: Prevalence, Assessment, and Management. Home Healthc Now. 2018 Mar/Apr;36(2):74-83. Doi: 10.1097/NHH.0000000000000652
2. Shimmura S, et al. Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol. 1995 Nov;79(11):1007-11. doi: 10.1136/bjo.79.11.1007
3. Cavuoto KM, et al. Relationship between the microbiome and ocular health. Ocul Surf. 2019 Jul;17(3):384-392. Doi: 10.1016/j.jtos.2019.05.006
4. Chisari G et al. The coadministration of Lactobacillus and Bifidobacterium strains associated with short chain fructo-oligosaccharides reduces the damage of the ocular surface caused by dry eye syndrome. Minerva Oftalmol 2016 June;58(2):31-8.
